Pediatric basal cell carcinoma burden and management preferences in Gorlin syndrome: A survey study To the Editor: Gorlin syndrome (GS) is a risk factor for early basal cell carcinomas (BCCs), 1 although its prevalence of fewer than 1 in 30,000 individuals 2 limits existing literature. There are sparse pediatric GS studies beyond case reports, creating a knowledge gap regarding childhood cutaneous findings and sequelae, including BCC age at onset, quantity, treatments, and impact. Herein, we describe a global survey to illustrate the clinical presentation, childhood perspectives, and BCC management trends for pediatric GS to improve the understanding and inform patient care.

The diagnostic trends of Gorlin syndrome (GS) in the pediatric population are not well understood. In an international survey conducted by the Gorlin Syndrome Alliance, 118 individuals who were diagnosed with GS when aged 18 years and under provided information about their diagnosis. Oral surgeons and dermatologists were the

No abstract